X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES

期刊標題檢索 ASSAY DRUG DEV 最新評論: Please translate the following paragraph into English and Japanese, a... (2021-12-30)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES]您好,您是該頁面的第 9687 位訪客。

期刊簡介
期刊名稱ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
LetPub Score
5.2
50 ratings
Rate

Reputation
6.4

Influence
3.6

Speed
8.8

期刊簡稱ASSAY DRUG DEV TECHN
ISSN1540-658X
E-ISSN1557-8127
h-index52
CiteScore
CiteScoreSJRSNIPCiteScore Rank
3.600.3170.525
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Drug Discovery
Q3100 / 157
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Molecular Medicine
Q3126 / 178

自引率 (2023-2024)6.20%自引率趨勢
掲載範囲
ASSAY and Drug Development Technologies provides access to novel techniques and robust tools that enable critical advances in early-stage screening. This research published in the Journal leads to important therapeutics and platforms for drug discovery and development. This reputable peer-reviewed journal features original papers application-oriented technology reviews, topical issues on novel and burgeoning areas of research, and reports in methodology and technology application.

ASSAY and Drug Development Technologies coverage includes:
-Assay design, target development, and high-throughput technologies-
Hit to Lead optimization and medicinal chemistry through preclinical candidate selection-
Lab automation, sample management, bioinformatics, data mining, virtual screening, and data analysis-
Approaches to assays configured for gene families, inherited, and infectious diseases-
Assays and strategies for adapting model organisms to drug discovery-
The use of stem cells as models of disease-
Translation of phenotypic outputs to target identification-
Exploration and mechanistic studies of the technical basis for assay and screening artifacts
官方網站http://www.liebertpub.com/overview/assay-and-drug-development-technologies/118/
在線稿件提交http://www.liebertpub.com/forauthors/assay-and-drug-development-technologies/118/
開放訪問No
出版商Mary Ann Liebert Inc.
主題領域医学
出版國/地區UNITED STATES
發行頻率隔月刊行
創刊年2002
每年文章數30每年文章數趨勢
黃金OA百分比2.04%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
BIOCHEMICAL RESEARCH METHODSSCIEQ469/85
PHARMACOLOGY & PHARMACYSCIEQ3259/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1540-658X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: >12 Week(s), or Invited contributions
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE METHODSH-index: 257

    CiteScore: 58.70
    Nature ProtocolsH-index: 206

    CiteScore: 29.10
    CURRENT OPINION IN BIOTECHNOLOGYH-index: 181

    CiteScore: 16.20
    BRIEFINGS IN BIOINFORMATICSH-index: 90

    CiteScore: 13.20
    MOLECULAR & CELLULAR PROTEOMICSH-index: 169

    CiteScore: 11.50
    BioChip JournalH-index: 16

    CiteScore: 7.70
    New BiotechnologyH-index: 74

    CiteScore: 11.40
    BIOINFORMATICSH-index: 335

    CiteScore: 11.20
    METHODSH-index: 132

    CiteScore: 9.80
    Expert Review of ProteomicsH-index: 53

    CiteScore: 7.60
    學科內最受檢索的期刊 頁面查看次數
    BIOINFORMATICS326423
    BRIEFINGS IN BIOINFORMATICS208141
    BMC BIOINFORMATICS173779
    NATURE METHODS141130
    Nature Protocols135243
    JOURNAL OF PROTEOME RESEARCH128138
    PLoS Computational Biology113815
    MOLECULAR & CELLULAR PROTEOMICS101393
    Journal of Proteomics99136
    METHODS88932
  •  

    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES] 的評論撰寫評論
作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 23:57:01 評論於
Please translate the following paragraph into English and Japanese, and use ":" and ":" as titles: Google Translate
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 10:24:18 評論於
2 weeks to 3 months
(0) 讚! | 维尔娜菲茨杰拉德

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 18:11:41 評論於
How long does the review process for a journal typically take?
(0) 讚! | 八坂篷蔚

作者: 陶宜三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 19:38:20 評論於
I received a letter from the journal, but I can't understand it. What should I do?
(0) 讚! | 陶宜三岁啦

作者: Keyon


領域: 医学
審稿時間: 4.0 month(s)
結果: 待定&不明


撰寫評論

2018-11-06 17:03:54 評論於
Articles are published bi-monthly; however, the review period is not particularly fast. Also, I don’t think that the reviewers are highly-regarded scientists in the field… this may be the reason for the lower quality research articles that are occasionally published in this journal.

(0) 讚! | Keyon

作者: 百花冰海


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-11-06 12:53:18 評論於
Bimonthly, the review may not be particularly fast, so some people may not want to submit, resulting in varying quality of submissions
(0) 讚! | 百花冰海

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*